title: Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues.
authors.forename: Tiago
authors.initials: T
authors.lastname: Torres
authors.forename: Iolanda
authors.initials: I
authors.lastname: Fernandes
authors.forename: Manuela
authors.initials: M
authors.lastname: Selores
authors.forename: Rosário
authors.initials: R
authors.lastname: Alves
authors.forename: Margarida
authors.initials: M
authors.lastname: Lima
mesh_terms: D000077608:Aprepitant; D002908:Chronic Disease; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D064729:Neurokinin-1 Receptor Antagonists; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology; D012751:Sezary Syndrome / Q000150:complications
chemical_list: D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D000077608:Aprepitant